|
HMGN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.67200000000101E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.595150E-04 |
| Normal-vs-Stage2 |
2.630200E-01 |
| Normal-vs-Stage3 |
1.918380E-01 |
| Normal-vs-Stage4 |
1.280200E-01 |
| Stage1-vs-Stage2 |
2.779400E-01 |
| Stage1-vs-Stage3 |
1.741840E-01 |
| Stage1-vs-Stage4 |
5.610400E-01 |
| Stage2-vs-Stage3 |
9.405400E-01 |
| Stage2-vs-Stage4 |
8.201400E-01 |
| Stage3-vs-Stage4 |
7.438200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.176400E-04 |
| Normal-vs-AfricanAmerican |
1.187000E-04 |
| Normal-vs-Asian |
1.841210E-01 |
| Caucasian-vs-AfricanAmerican |
3.464600E-01 |
| Caucasian-vs-Asian |
7.738400E-01 |
| AfricanAmerican-vs-Asian |
5.013200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.96280000000538E-05 |
| Normal-vs-Female |
1.481770E-03 |
| Male-vs-Female |
9.220000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.217800E-03 |
| Normal-vs-Extreme_Weight |
1.298200E-03 |
| Normal-vs-Obese |
2.153000E-04 |
| Normal-vs-Extreme_Obese |
4.081200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.226600E-01 |
| Normal_Weight-vs-Obese |
4.872200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.702400E-02 |
| Extreme_Weight-vs-Obese |
5.190000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.324400E-02 |
| Obese-vs-Extreme_Obese |
1.490490E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.479900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.22629999996538E-06 |
| Normal-vs-Age(61-80Yrs) |
1.896340E-03 |
| Normal-vs-Age(81-100Yrs) |
3.480400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.272200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.795200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.047000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.838000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.501000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.776800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.69029998278825E-09 |
| Normal-VS-Type2 PRCC |
5.542000E-01 |
| Normal-VS-KIRP CIMP |
1.361640E-01 |
| Normal-VS-Unclassified PRCC |
2.805400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.96442861977175E-12 |
| Type1 PRCC-VS-KIRP CIMP |
1.27429999996487E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
7.391200E-04 |
| Type2 PRCC-VS-KIRP CIMP |
2.354300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.697700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.908600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.682400E-01 |
| Normal-vs-N1 |
8.863800E-03 |
| Normal-vs-N2 |
9.474600E-01 |
| N0-vs-N1 |
5.781800E-02 |
| N0-vs-N2 |
7.193800E-01 |
| N1-vs-N2 |
2.389000E-01 |
|
|
